SoftMaxx AI sells no peptides and takes no vendor money.
Human, small or uncontrolled We found no peptide hair product with evidence close to minoxidil or finasteride; the best peptide study we found matched 3% minoxidil in just 32 people.[1][2]
The tier describes the evidence for peptides' effect on hair growth; stronger evidence on this page concerns minoxidil and finasteride.
The verdict
| Ingredient | Best human study | Placebo group? | What it showed |
|---|---|---|---|
| Minoxidil (approved drug) | Randomized trials pooled in a meta-analysis and a network meta-analysis | Yes | Proven for pattern hair loss [3] [4] |
| Finasteride (approved drug) | Two 1-year trials, 1,553 men, with a second-year extension | Yes | Proven for male pattern hair loss [5] |
| Blend with acetyl tetrapeptide-3 (Capixyl's peptide, as sellers describe it) | 32 people vs 3% minoxidil, 24 weeks | No | About 8% more terminal hairs in both groups [1] |
| Procapil (includes biotinoyl tripeptide-1, as sellers describe it) | Tested on top of PRP; 54 and 160 people | No | Mixed [6] [7] |
| GHK (named without copper), plus 5-ALA | 45 men, 6 months | Yes | Cannot be credited to GHK-Cu [8] |
| GHK-Cu, AHK-Cu (copper peptides) | None found in people | — | Follicles in a dish (AHK-Cu) and a rat study of another copper-binding peptide [9] [10] |
Peptide serums are, at most, unproven add-ons. We found no peptide evidence strong enough to replace the approved drugs.
- Expert review A 2025 network meta-analysis confirms the efficacy of minoxidil, finasteride and dutasteride for male pattern hair loss; a 2022 one compared the three with each other.[2][4]
- Claim as marketed
Peptide serums are a natural replacement for minoxidil or finasteride
No supporting study We found no peptide product with placebo-controlled evidence comparable to the trials behind minoxidil and finasteride, and a 2025 review says most studies of these topical actives were small.[3][11]
The benchmark: minoxidil and finasteride
Both are FDA-approved for pattern hair loss, and a meta-analysis of randomized trials found minoxidil (in men and in women) and finasteride (in men) superior to placebo [3]. Any peptide claim should be read against them. Your prescriber or pharmacist decides which fits you.
- Human RCT Finasteride was tested in two 1-year trials of 1,553 men aged 18–41 with male pattern hair loss, and 1,215 continued into a second year.[5]
- Human RCT A 48-week trial of 393 men compared 5% minoxidil, 2% minoxidil and placebo.[12]
- Expert review In a 2025 network meta-analysis, 5% minoxidil twice daily ranked as the most effective over-the-counter topical.[13]
Capixyl and acetyl tetrapeptide-3: one small trial
The one trial we found tested a blend of biochanin A, acetyl tetrapeptide-3 and ginseng extracts [1]. None of the abstracts we read lists Capixyl's ingredients.
The trial was randomized and triple-blind, but small [1]. Its comparison arm was 3% minoxidil, and it had no placebo group [1]. It tested a blend, so the peptide's own share is unknown.
- Human RCT In 32 adults over 24 weeks, a blend with acetyl tetrapeptide-3 raised terminal hair counts by 8.3%. 3% minoxidil raised them by 8.7%.[1]
- Claim as marketed
Capixyl blocks DHT
No supporting study We found no human study measuring DHT with Capixyl. A 2025 review of topical hair actives, Capixyl among them, says most were tested as multi-ingredient formulas in small studies, often with conflicts of interest.[11]
Procapil: always tested with something else
As sellers describe it, Procapil includes biotinoyl tripeptide-1; we found no Procapil abstract that lists its ingredients. CosIng lists biotinoyl tripeptide-1 as the reaction product of biotin and tripeptide-1 (CosIng entry). We found no trial that isolates the peptide.
We found no evidence that the biotin part feeds hair.
- Human, small or uncontrolled In a randomized trial of 54 men, Procapil with PRP did worse than Redensyl, saw palmetto and biotin with PRP.[6]
- Human, small or uncontrolled In a non-randomized study of 160 patients, Procapil with PRP beat PRP alone on satisfaction scores.[7]
- Expert review A 2025 review flags small samples, no comparison with standard therapy, and conflicts of interest across these topical studies.[11]
Copper peptides (GHK-Cu, AHK-Cu): no human hair trials found
The copper-peptide hair data we found come from lab dishes [9] and rats [10]. We found no controlled human hair-count trial of GHK-Cu or AHK-Cu.
One 45-man placebo-controlled trial tested GHK, named without copper, combined with 5-aminolevulinic acid [8]. Its result cannot be credited to GHK-Cu.
- In vitro (cells) A copper tripeptide lengthened isolated human hair follicles kept alive in a dish.[9]
- Animal A different copper-binding peptide enlarged follicles in rats.[10]
- Human, small or uncontrolled A placebo-controlled trial in 45 men tested a complex of 5-ALA and GHK once daily for 6 months; the paper names GHK, not GHK-Cu.[8]
- Claim as marketed
AHK-Cu blocks DHT like finasteride
No supporting study We found no study showing an anti-DHT effect for AHK-Cu. Its hair study measured follicle growth in a dish, not DHT.[9]
Redensyl: not a peptide, as sellers describe it
As sellers describe it, Redensyl is not a peptide.
- Human RCT A 44-person single-blind trial of a lotion with two patented formulas, Redensyl and Sepicontrol A5, against its vehicle reported mainly within-group changes.[14]
Safety
Peptide serums report few side effects, but their trials are too small to catch rare ones [11]. Calling a serum "natural" does not make it safer or better tested. Injected peptides sold online lack established human safety profiles [15].
Doses used in studies (not a recommendation)
These are the amounts given to the people, animals or cells in the cited studies, copied as reported. They are a record of what was tested, not dosing instructions, and nothing here says what you should take.
| Studied in | Route | Amount reported | How often | How long | n | Source |
|---|---|---|---|---|---|---|
| human | oral finasteride (approved drug) | 1 mg/day | daily | 1–2 years | 1553 | [5] Men aged 18–41. Approved drug; your prescriber sets your dose. |
| human | topical minoxidil (approved drug) | 5% or 2% solution | twice daily | 48 weeks | 393 | [12] Men aged 18–49; placebo arm included. |
| human | topical blend (acetyl tetrapeptide-3 + biochanin A + ginseng) | 1 mL | twice daily | 24 weeks | 32 | [1] Compared with 3% minoxidil; no placebo. |
| human | not stated in the abstract (complex of 5-ALA and GHK) | 50 or 100 mg/mL | once daily | 6 months | 45 | [8] Men with pattern hair loss; placebo-controlled. |
| human | topical Procapil + PRP | 5% Procapil | Procapil twice daily, plus PRP (4 sessions, 4 weeks apart, stated for the PRP-only group) | 6 months | 160 | [7] Non-randomized; 80 per arm. |
Side effects and risks
- Expert review Finasteride and related drugs: about 1.9-fold higher risk of sexual side effects than placebo[16]
- Human RCT 5% minoxidil: more itching and local irritation than 2%[12]
- Human RCT Blend with acetyl tetrapeptide-3: no local reactions reported (one scalp eczema case in the 3% minoxidil group)[1]
- Expert review Topical hair actives: milder side-effect profile in mostly small studies[11]
Report a side effect
If something went wrong after using any product, tell a clinician and report it. Reports are how regulators find contaminated or mislabeled products.
- FDA MedWatch (United States)
- Canada Vigilance Program (Canada)
Common questions
Do peptides for hair growth really work?
Not to the standard of minoxidil or finasteride. The best peptide study had 32 people and no placebo group, and we found no human hair trial of copper peptides.[1][9]
GHK-Cu vs minoxidil: which is better?
Minoxidil. Network meta-analyses of trials confirm its efficacy; for copper peptides we found only follicle-culture and rodent data.[2][4][9][10]
Capixyl vs minoxidil: which is better?
One 32-person trial of a blend with acetyl tetrapeptide-3 (Capixyl's peptide, as sellers describe it) found similar gains to 3% minoxidil. It was too small to prove equivalence, and in a 2025 network meta-analysis, 5% minoxidil twice daily ranked as the most effective over-the-counter topical.[1][4][13]
Does Procapil block DHT?
We found no human study showing it. A 2025 review of topical hair actives, Procapil among them, found mostly small, multi-ingredient studies, often with conflicts of interest.[11]
Are peptides for hair growth safe?
Small studies report few side effects, but they are small, so uncommon harms could be missed, and we found no long-term safety studies.[11]
References
Every reference below was matched to its PubMed or DOI record (title checked) before publication. "Verified" means the paper exists and is the one named; what it supports is stated next to each claim.
An Herbal Extract Combination (Biochanin A, Acetyl tetrapeptide-3, and Ginseng Extracts) versus 3% Minoxidil Solution for the Treatment of Androgenetic Alopecia: A 24-week, Prospective, Randomized, Triple-blind, Controlled Trial.
PubMed 33584955Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis.
PubMed 35107565 DOIThe effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
PubMed 28396101 DOIRelative Efficacy of Conventional Monotherapies and Select Nonconventional, Over-the-Counter Products for Male Androgenetic Alopecia: A Network Meta-Analysis Study.
PubMed 41051009 DOIFinasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.
PubMed 9777765 DOIA Comparative Study of Topical Procapil With Platelet-Rich Plasma Therapy Versus Topical Redensyl, Saw Palmetto, and Biotin With Platelet-Rich Plasma Therapy in the Treatment of Androgenetic Alopecia.
PubMed 37292551 DOICOMPARISON OF PLATELET RICH THERAPY ALONE WITH PLATELET RICH THERAPY ALONG WITH DAILY TOPICAL 5% PROCAPIL APPLICATION FOR THE TREATMENT OF ANDROGENETIC ALOPECIA.
PubMed 39609969 DOIEfficacy of a Complex of 5-Aminolevulinic Acid and Glycyl-Histidyl-Lysine Peptide on Hair Growth.
PubMed 27489425 DOIThe effect of tripeptide-copper complex on human hair growth in vitro.
PubMed 17703734 DOIChemical agents and peptides affect hair growth.
PubMed 8326148 DOITopical Alternatives for Hair Loss: Beyond the Conventional.
PubMed 40654553 DOIA randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
PubMed 12196747 DOIComparative Effect of Conventional and Non-Conventional Over-the-Counter Treatments for Male Androgenetic Alopecia: A Systematic Review and Network Meta-Analysis.
PubMed 40869239 DOIA randomized, single-blinded, vehicle-controlled study of a topical active blend in the treatment of androgenetic alopecia.
PubMed 32473084 DOIDangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs.
PubMed 42757290Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis.
PubMed 34747724 DOI